Table 1.

Patient characteristics

Characteristic	Total included [n = 20]
Sex
Male	7 (35)
Female	13 (65)
Age, years [median (IQR)]	67.5 [55–73.5]
Performance status
ECOG 0	10 (50)
ECOG 1	10 (50)
Race
Caucasian	16 (80)
Asian	3 (15)
African	1 (5)
Current smoker	0 (0)
Erlotinib dose, mg
150	17 (85)
100	2 (10)
50	1 (5)

Data are expressed as n (%) unless otherwise specified

ECOG Eastern Cooperative Oncology Group, IQR interquartile range